glp-1 diy Wegovy Pill vs. Foundayo: Which Oral Is Better for Weight Loss? The GLP-1 Revolution: The Science,
Description
Roughly 27% of the worlds population could meet eligibility criteria for GLP-1 therapy
The need-to-know this morning Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting that the drug led to significant weight loss in a mid-stage trial
HPG axis central effects: hypothalamus and pituitary Evidence on the potential neuroendocrine actions of GLP-1 on HPG axis was provided by an in vitro study in a rodent hypothalamic neuronal cell line (GT1-7) that reported a dose-dependent stimulating effect of GLP-1 on GnRH release, in association with a prompt increase in the plasma LH levels following the intracerebroventricular injection of GLP-1 in male rats [34]
[DOI] [PubMed] [Google Scholar] [70].Lorenz M, Lawson F, Owens D, et al
